Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer.

NCT00471146 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

630

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Pancreatic Ductal

Interventions

DRUG: AG-013736
DRUG: Gemcitabine
DRUG: Gemcitabine
DRUG: placebo

Sponsor

Pfizer